Bitcion Price Holds Below $110K as QCP Sees ‘Tight Range’; Altcoins Outperform
By James Van Straten (All times ET unless indicated otherwise) Bitcoin treasury-holding companies continue to be a significant driver of…
Tag: Outperform
XRP maintains 200-EMA, poised for a bounce, but will these altcoins below $1 outperform?
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes…
RBC Capital Maintains ‘Outperform’ Rating on Adobe (ADBE), Keeps $480 Price Target
On June 5, RBC Capital maintained its ‘Outperform’ rating on Adobe Inc. (NASDAQ:ADBE), leaving the price target unchanged at $480.…
These EVs Far Outperform Their EPA Range On The Highway
Consumer Reports tested 30 EVs to see which ones measure up to their stated EPA range estimates. Most vehicles that…
FTSE 100 Set to Outperform as Trade Worries Rattle Markets
FTSE 100 Set to Outperform as Trade Worries Rattle Markets www.bloomberg.com #FTSE #Set #Outperform #Trade #Worries #Rattle #Markets
BMO Capital Hikes AutoZone Price Target to $4,100, Affirms Outperform Stance
AutoZone, Inc. (NYSE:AZO) is well-positioned to continue edging higher. That’s the sentiment echoed on May 27 by BMO Capital as…
William Blair Initiates Coverage of Oklo (OKLO) Stock with Outperform Rating
On May 28, William Blair analyst Jed Dorsheimer initiated coverage on Oklo Inc. (NYSE:OKLO)’s stock with an “Outperform” rating without…
Mizuho Increases Block’s (XYZ) Price Target, Keeps Outperform Rating
On Tuesday, May 27, Mizuho Securities increased the price target for Block, Inc. (NYSE:XYZ), previously known as Square, to $71…
Oppenheimer Downgrades Prothena Corporation (NASDAQ:PRTA) to Perform from Outperform
Oppenheimer downgraded Prothena Corporation plc (NASDAQ:PRTA) to Perform from Outperform on May 27 without a price target. This rating update…
William Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial Setback
Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on May 27 with…